Cited by

• Effect of psyllium fiber supplementation on C-reactive protein: the trial to reduce inflammatory markers (TRIM).

  King DE, Mainous AG 3rd, Egan BM, Woolson RF, Geesey ME. King DE, et al. Ann Fam Med. 2008 Mar-Apr;6(2):100-6. doi: 10.1370/afm.819. Ann Fam Med. 2008. PMID: 18332401 Free PMC article. Clinical Trial.
• Inflammation markers are associated with cardiovascular diseases risk in adolescents: the Young Hearts project 2000.

  Wijnstok NJ, Twisk JW, Young IS, Woodside JV, McFarlane C, McEneny J, Hoekstra T, Murray L, Boreham CA. Wijnstok NJ, et al. J Adolesc Health. 2010 Oct;47(4):346-51. doi: 10.1016/j.jadohealth.2010.04.008. Epub 2010 May 20. J Adolesc Health. 2010. PMID: 20864003 Free PMC article.
• Estimating heterogeneity of physical function treatment response to caloric restriction among older adults with obesity.

  Beavers DP, Hsieh KL, Kitzman DW, Kritchevsky SB, Messier SP, Neiberg RH, Nicklas BJ, Rejeski WJ, Beavers KM. Beavers DP, et al. PLoS One. 2022 May 5;17(5):e0267779. doi: 10.1371/journal.pone.0267779. eCollection 2022. PLoS One. 2022. PMID: 35511858 Free PMC article. Clinical Trial.
• Atrial natriuretic peptide inhibits the production of adipokines and cytokines linked to inflammation and insulin resistance in human subcutaneous adipose tissue.

  Moro C, Klimcakova E, Lolmède K, Berlan M, Lafontan M, Stich V, Bouloumié A, Galitzky J, Arner P, Langin D. Moro C, et al. Diabetologia. 2007 May;50(5):1038-47. doi: 10.1007/s00125-007-0614-3. Epub 2007 Feb 23. Diabetologia. 2007. PMID: 17318625
• Change in C-reactive protein after Roux-en-Y gastric bypass through 7 years of follow-up.

  Hinerman AS, Barinas-Mitchell EJM, El Khoudary SR, Courcoulas AP, Wahed AS, King WC. Hinerman AS, et al. Surg Obes Relat Dis. 2022 Jul;18(7):902-910. doi: 10.1016/j.soard.2022.03.009. Epub 2022 Mar 18. Surg Obes Relat Dis. 2022. PMID: 35589527 Free PMC article.